LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Transdermal Technology Starton Therapeutics has launched STARSILON, a novel proprietary transdermal PATCH delivery platform, offering a unique method for drug delivery. This innovative technology could present a lucrative sales opportunity for partnerships in the pharmaceutical industry.

Strategic Investor Partnerships LOVE Pharma and other investors have shown confidence in Starton Therapeutics by making significant strategic investments. Leveraging these investor partnerships not only boosts financial health but also opens doors for potential collaborations and sales growth.

Expert Board Additions The recent addition of Moses Dodo to Starton Therapeutics' Board of Directors brings expertise and potentially new networking opportunities. Leveraging the expertise of renowned board members can aid in building relationships that lead to increased sales and business expansion.

Clinical Development Success Starton Therapeutics' announcement of initial key safety and efficacy signals with STAR-LLD in patients with multiple myeloma showcases success in clinical developments. This success story could attract partnerships or sales inquiries from pharmaceutical companies looking to enhance their treatment options.

FDA Clearance for Drug Application The FDA clearance of IND application for STAR-OLZ TDS marks a significant milestone for Starton Therapeutics in advancing their treatment for CINV. This regulatory approval could pave the way for potential sales agreements or licensing deals with other healthcare companies.

Similar companies to Starton Therapeutics

Starton Therapeutics Tech Stack

Starton Therapeutics uses 8 technology products and services including cdnjs, WordPress, Font Awesome, and more. Explore Starton Therapeutics's tech stack below.

  • cdnjs
    Content Delivery Network
  • WordPress
    Content Management System
  • Font Awesome
    Font Scripts
  • DataTables
    Javascript Libraries
  • Amazon Web Services
    Platform As A Service
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • HSTS
    Security

Media & News

Starton Therapeutics's Email Address Formats

Starton Therapeutics uses at least 1 format(s):
Starton Therapeutics Email FormatsExamplePercentage
FLast@startontx.comJDoe@startontx.com
50%
FLast@startontx.comJDoe@startontx.com
50%

Frequently Asked Questions

Where is Starton Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Starton Therapeutics's main headquarters is located at 215 College Rd 300 Paramus, New Jersey 07652 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Starton Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Starton Therapeutics's official website is startontx.com and has social profiles on LinkedIn.

How much revenue does Starton Therapeutics generate?

Minus sign iconPlus sign icon
As of June 2024, Starton Therapeutics's annual revenue reached $1.8M.

What is Starton Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Starton Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Starton Therapeutics have currently?

Minus sign iconPlus sign icon
As of June 2024, Starton Therapeutics has approximately 13 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: J. O.Co-Founder: K. C. P.Director Of Product Development: R. H.. Explore Starton Therapeutics's employee directory with LeadIQ.

What industry does Starton Therapeutics belong to?

Minus sign iconPlus sign icon
Starton Therapeutics operates in the Biotechnology Research industry.

What technology does Starton Therapeutics use?

Minus sign iconPlus sign icon
Starton Therapeutics's tech stack includes cdnjsWordPressFont AwesomeDataTablesAmazon Web ServicesPHPYoast SEOHSTS.

What is Starton Therapeutics's email format?

Minus sign iconPlus sign icon
Starton Therapeutics's email format typically follows the pattern of . Find more Starton Therapeutics email formats with LeadIQ.

How much funding has Starton Therapeutics raised to date?

Minus sign iconPlus sign icon
As of June 2024, Starton Therapeutics has raised $971K in funding. The last funding round occurred on Oct 11, 2023 for $971K.

When was Starton Therapeutics founded?

Minus sign iconPlus sign icon
Starton Therapeutics was founded in 2017.
Starton Therapeutics

Starton Therapeutics

Biotechnology ResearchNew Jersey, United States11-50 Employees

Starton Therapeutics is a clinical-stage biotechnology company that is transforming standard-of-care therapies with proprietary dermal technology, so people with cancer can receive continuous treatment to live better, longer. 

Chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) are the most common blood cancers in the United States. There is no treatment to help people with CLL to stay in remission, and while advances in treatment have provided people with MM a multitude of treatment options, they struggle with long-term tolerance of high doses, which may be more effective but come with a multitude of side effects. 

Starton’s team of some of the best in clinical development and hematology/oncology have come together to change the fate for people struggling with the impact of their diseases. If dose-related side effects can be reduced and people can tolerate maintenance therapy for decades to help stay in remission, these cancers – which were previously a death sentence – would become more akin to chronic diseases, with a long lifespan and healthy quality of life. 

Starton is one of the few life sciences companies funded exclusively by individual investors. We have a business model that is lower risk, faster to market and less capital intensive than biotech companies developing medicines from scratch. 

Section iconCompany Overview

Headquarters
215 College Rd 300 Paramus, New Jersey 07652 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $971K

    Starton Therapeutics has raised a total of $971K of funding over 7 rounds. Their latest funding round was raised on Oct 11, 2023 in the amount of $971K.

  • $10M

    Starton Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $971K

    Starton Therapeutics has raised a total of $971K of funding over 7 rounds. Their latest funding round was raised on Oct 11, 2023 in the amount of $971K.

  • $10M

    Starton Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.